Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/16 → 11/1/19 |
Funding
- Covance Inc. (Prot #VX16-152-102 // Prot #VX16-152-102)
- Vertex Pharmaceuticals Incorporated (Prot #VX16-152-102 // Prot #VX16-152-102)
Prot #VX16-152-102: A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis
- Jain, Manu (PD/PI)
- Lam, Anna P (Co-Investigator)
- Prickett, Michelle (Co-Investigator)
- Sala, Marc A (Co-Investigator)
Project: Research project